Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Fuzapladib is dosed at 0.1 mg/kg IV Single dose in dogs, per FDA conditional approval (Laverdia-CA1); FDA openFDA Adverse Event Database. Fuzapladib is used in dogs for Acute onset of clinical signs of anaphylaxis. Routes documented in dogs: IV. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Fuzapladib in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Panoquell-CA1
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| IV | 0.1 mg/kg | Single dose | Single IV injection; may repeat once if needed | Acute onset of clinical signs of anaphylaxis | Moderate | FDA conditional approval (Laverdia-CA1); FDA openFDA Adverse Event Database |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Inhibits cytosolic phospholipase A2 (cPLA2), reducing arachidonic acid release from cell membranes and subsequent production of both prostaglandins and leukotrienes, providing broad anti-inflammatory effects.
New veterinary drug — limited long-term safety data. Monitor for GI signs and injection site reactions. Currently indicated for canine use only.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Fuzapladib dose range in dogs, with cited source references: IV 0.1 mg/kg Single dose. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Fuzapladib in dogs: IV.
Cited course lengths for Fuzapladib in dogs include: Single IV injection; may repeat once if needed. Duration depends on the indication — match it to the specific dose rule in the table above.
Fuzapladib is indicated in dogs for: Acute onset of clinical signs of anaphylaxis.
These are general warnings for Fuzapladib across species; consult the dog dosing table above for species-specific guidance. New veterinary drug — limited long-term safety data. Monitor for GI signs and injection site reactions. Currently indicated for canine use only.
Why a species-specific page? Fuzapladib pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.